Whalesbook
Dekho, UPL ke investors aaj thode confused honge. Company ne March 2026 quarter ke results mein toh kamaal hi kar diya. Revenue 17.7% badh kar ₹18,335 crore pahunch gaya, aur Net Profit bhi 18% jump karke ₹1,061 crore ho gaya. Lekin, share price seedha neeche gir gaya! Kyun? Asli masla kuch aur hi hai.
Jo asli problem hai, woh hai company ke margins ka dabna. EBITDA margins ghata kar 19.41% ho gaye hain, pichle saal yeh 20.49% the. Matlab, company ke operational profits kam ho rahe hain, chahe revenue kitna bhi badh jaye. Iske peeche input costs ka badhna ya pricing power kam hona ho sakta hai. Aur upar se, China mein agrochemicals ki bharpoor supply ke karan global prices kam ho rahi hain, jis se UPL ko aur mushkil ho rahi hai.
Isi wajah se, analysts bhi thode tensed hain. Motilal Oswal Financial Services ne toh FY27 aur FY28 ke earnings estimates ko 15% aur 13% tak kam kar diya hai, kyunki unhe lagta hai ki effective tax rate badhne se profit kam ho sakta hai. Unhone stock par 'Neutral' rating aur ₹600 ka target price rakha hai. Morgan Stanley ne bhi 'Equal Weight' rating aur ₹658 ka target dekar thoda caution dikhaya hai. Agar valuation ki baat karein, toh UPL ka P/E ratio lagbhag 29.38x hai, jo kuch global competitors jaise BASF SE ke aas paas hai, par Syngenta AG ke comparison mein kaafi zyada hai. Lekin, iske bawajood analysts ki rating aur earnings estimates mein giraawat dikh rahi hai.
Aage chal kar, UPL ke saamne global agrochemical market mein challenges to rahengi. Demand badhne ki umeed hai par overcapacity aur geopolitical risks bhi hain. Company innovation aur sustainable solutions par focus kar rahi hai, par filhaal investors ki nazar margins aur higher tax ke impact par hi rahegi.